Sandoz, Teva, Others Face AbbVie Drug Patent Battle
AbbVie has slapped rival drugmakers including Sandoz and Teva with a patent suit in Delaware federal court over its brand-name endometriosis medication Orilissa, arguing that the accused rivals are jumping the...To view the full article, register now.
Already a subscriber? Click here to view full article